EXoPERT is a biotech company focusing on detecting cancer early by liquid biopsy. Founded in 2018, EXoPERT is developing a Novel Liquid biopsy technology that detects cancer at an early stage, and we aim to expand our impact in healthcare through continued research and development.
We are using our exosome platform to detect serious diseases early by a single draw of blood.
For more information, please visit exopert.com.
Company Details
- Employees
- 14
- Founded
- -
- Address
- 10, Wangsan-Ro, Dongdaemun-Gu, Seoul,02582,korea, Republic Of
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.exopert.com/
- Keywords
- Cancer Detection, Cancer Screening, Multi Cancer Early Detection, SERS, Early Diagnosis, Liquid Biopsy.
- HQ
- Seoul
Exopert Questions
Exopert's website is https://www.exopert.com/
Exopert's LinkedIn profile is https://kr.linkedin.com/company/exopert
Exopert has
14 employees.
View email and phone details for 14
employees at Exopert.
Exopert's industry is
Biotechnology Research
Exopert's top competitors are
Dwd Healthcare,
Eyechip Corporation,
The Dabom Inc.,
Daton,
Texas Built Roofing,
Coremovement Ltd,
Htnb Inc.,
Qsimplus Co.,ltd.,
Sp Aerospace,
Cream-Off.
Exopert's categories are Biotechnology Research
Exopert's founding year is 2018
